Device and method for analysis of tissue constructs

US11066630B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11066630-B2
Application numberUS-201615739639-A
CountryUS
Kind codeB2
Filing dateJul 1, 2016
Priority dateJul 1, 2015
Publication dateJul 20, 2021
Grant dateJul 20, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides an integrated microphysiological device and fabrication methods thereof, as well as methods of use to perform biological assays.

First claim

Opening claim text (preview).

What is claimed is: 1. A microphysiology device for mimicking a biological tissue, the device comprising: a body having a top compartment having a first fluid channel, and a bottom compartment having a second fluid channel, the top and bottom compartments being separated by a porous membrane that is partially or entirely optically transparent, wherein the porous membrane comprises at least one agent adapted to support adherence of a living cell, wherein the porous membrane comprises pores fluidly connecting the first and second fluid channels, the pores dimensioned between about 0.2 microns and 10 microns, and the first and second fluid channels having a width between about 1 and 5 mm, a length between about 5 and 20 mm, and a height between about 50 and 500 μm, wherein support pillars with a diameter between about 50 and 250 μm are distributed within the first and second fluid channels, and wherein the length of the first fluid channel is disposed perpendicular to the length of the second fluid channel. 2. The device of claim 1 , wherein the biological tissue is a functional organ. 3. The device of claim 2 , wherein the organ is mammalian. 4. The device of claim 3 , wherein the mammal is human. 5. The device of claim 1 , further comprising: at least two access ports through the body, wherein the first access port provides a fluid path through the body into the top compartment, and the second access port provides a fluid path though the body into the bottom compartment, and wherein a pressure applied to the top compartment through the first access port introduces a compressive stress gradient on a cell adhered to the membrane. 6. The device of claim 5 , wherein the first access port is fluidly coupled to a fluid supply. 7. The device of claim 6 , wherein the fluid supply is gas. 8. The device of claim 1 , further comprising at least one access hole through the body providing access to the bottom compartment, top compartment, or both. 9. The device of claim 1 , wherein the bottom compartment is coated with at least one molecule that supports adherence of a living cell. 10. The device of claim 9 , wherein the agent is selected from the group consisting of polypeptide, entactin, glycoprotein, collagen, fibronectin, laminin, poly-D-lysine, poly-L-ornithine, proteoglycan, vitronectin, polysaccharide, hydrogel, and combinations thereof. 11. The device of claim 1 , wherein the agent is selected from the group consisting of polypeptide, entactin, glycoprotein, collagen, fibronectin, laminin, poly-D-lysine, poly-L-ornithine, proteoglycan, vitronectin, polysaccharide, hydrogel, and combinations thereof. 12. The device of claim 1 , wherein the body, porous membrane, or both, comprise a material selected from the group consisting of polycarbonate, polyester, nylon, polyethersulfone, polypropylene, polytetrafluoroethylene, polyvinylidene difluoride, cellulose acetate, polydimethylsiloxane, inorganic ceramic and combinations thereof. 13. The device of claim 1 , wherein at least one side of the porous membrane is seeded with a layer of a first cell type, and wherein the bottom compartment is seeded with a layer of a second cell type. 14. The device of claim 13 , wherein the first and second cell types are selected from the group consisting of stem, epithelial, endothelial, smooth-muscle, neural, cardiac, and immune cells. 15. The device of claim 13 , wherein the top side of the membrane is coated with airway-derived epithelial cells, and the bottom compartment is coated with airway-derived smooth-muscle cells. 16. The device of claim 13 , wherein magnetic beads are attached to cells of the first, second, or both cell types. 17. The device of claim 16 , wherein the magnetic beads are ferromagnetic or paramagnetic. 18. The device of claim 13 , wherein magnetic beads are attached to cells in the bottom compartment. 19. The device of claim 18 , wherein the magnetic beads are ferromagnetic, ferromagnetic or paramagnetic. 20. The device of claim 1 , wherein one side of the porous membrane is seeded with a layer of a first cell type, and an opposing side of the porous membrane is seeded with a layer of a second cell type. 21. The device of claim 1 , wherein a bottom side of the porous membrane is seeded with a layer of a first cell type, and wherein the bottom compartment is seeded with a layer of a second cell type. 22. The device of claim 1 , wherein a top side of the porous membrane is seeded with a layer of a first cell type, and wherein the bottom compartment is seeded with a layer of a second cell type. 23. A method for performing a biological assay comprising: providing a device of claim 1 , wherein at least one side of the porous membrane and the bottom compartment are coated with living cells, the cells in the bottom compartment being attached to magnetic beads; applying a magnetic field in a first direction to magnetize the magnetic beads attached to the cells; and monitoring behavior of the cells in the bottom compartment by applying a magnetic field oscillating in a second direction that forces the magnetic beads into a twisting motion. 24. The method of claim 23 , wherein the first direction is perpendicular to the second direction. 25. The method of claim 23 , wherein the first direction is in a plane parallel to the top surface of the porous membrane and the second direction is perpendicular to the top surface of the porous membrane. 26. The method of claim 23 , wherein the twisting motion comprises movement in the first direction and movement in the second direction. 27. The method of claim 26 , further comprising recording the movement in the first direction. 28. The method of claim 26 , further comprising recording the movement in the second direction. 29. The method of claim 27 , wherein the recording comprises a microscope imaging the magnetic beads. 30. A method for determining an effect of at least one stimulus on cells within the device set forth in claim 1 , the method comprising: applying a stimulus to the top compartment, bottom compartment, or both; and monitoring behavior of cells in the bottom compartment. 31. The method of claim 30 , wherein the stimulus is physical, chemical, or biological in nature. 32. The method in claim 31 , wherein the stimulus is physical. 33. The method of claim 32 , wherein the physical stimulus is an application of pressure to the top compartment at a level between about 0 to 100 cm H2O to cause compressive stress on the cells attached to the membrane. 34. The method of claim 30 , wherein monitoring comprises assaying secretion and biochemical activity profiles, microrheological characteristics, or mechanical properties of the cells. 35. The method of claim 30 , wherein the stimulus is a biological molecule. 36. The method of claim 35 , wherein the biological molecule is a ligand selected from the group consisting of drugs or drug candidates, natural compounds, toxins, smoke, allergens, molds, pollen, nanoparticles, mineral dust, nucleic acids, viruses, bacteria, microbes, cells, hormones, growth factors, and cytokines. 37. The method of claim 30 , further comprising: applying a magnetic field in a first direction to magnetize magneti

Assignees

Inventors

Classifications

  • Artificially induced pluripotent stem cells, e.g. iPS · CPC title

  • C12M21/08Primary

    for producing artificial tissue or for ex-vivo cultivation of tissue (prostheses A61F2/00, grafts A61L27/00) · CPC title

  • Microfluidic devices; Capillary tubes (integrated microfluidic structures B01L3/5027; microreactors B01J19/0093) · CPC title

  • Membranes; Filters (filters or filtration in general B01D24/00-B01D41/00) · CPC title

  • Chemical, biochemical or biological means, e.g. plasma jet, co-culture · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11066630B2 cover?
The present invention provides an integrated microphysiological device and fabrication methods thereof, as well as methods of use to perform biological assays.
Who is the assignee on this patent?
Univ Johns Hopkins
What technology area does this patent fall under?
Primary CPC classification C12M21/08. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).